Form 4 for LLY Lilly (Eli)
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0000059478-22-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-11 | 2022-02-09 | LLY | Fry Stephen F | SVP, HR, Diversity | A - Grant | $243.27 | +12.3K | 152.6K | +9% | +$3.00M |
| D | 2022-02-11 | 2022-02-09 | LLY | Fry Stephen F | SVP, HR, Diversity | A - Grant | $0.00 | +7,264 | 7,264 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | A | A | 12,339 | $243.27 | 152,631 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2022-02-09 | A | A | 7,264 | $0.00 | 7,264 | D | — · 2023-02-01 to 2023-02-01 | 7,264 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |